TAKE THIS POLL |
|
|
- Pa. Court Mulls Class Decertification in Off-Label Drug Case 21 Nov 2009 05:14 GMT
... A class can't be decertified unless there are substantial changes to the facts of a case, nor ...
- Reports Of Cartilage Damage Associated With Local Anesthetics 16 Nov 2009 17:55 GMT
... within the maximum dose listed in the drug label (400mg/day), the maximum labeled daily dose was ... or regional anesthesia or analgesia. The approved drug labels for local anesthetics do not include an ...
- Reports Of Cartilage Damage Associated With Local Anesthetics, Pain Pumps 17 Nov 2009 13:35 GMT
... within the maximum dose listed in the drug label (400mg/day), the maximum labeled daily dose was ... or regional anesthesia or analgesia. The approved drug labels for local anesthetics do not include an ...
- Continuous Infusions of Local Anesthetics May Lead to Chondrolysis 16 Nov 2009 14:58 GMT
... 48 hours, or 250 mg/day. That falls within the maximum dose listed on the drug label (400 mg/day), the FDA said, but these parameters were determined for approved uses, not off-label ...
- Dialysis, Kidney Transplant Patients Face Higher Risk of NSF from Gadolinium Agents 20 Nov 2009 20:36 GMT
... Dialysis, Kidney Transplant Patients Face Higher Risk of NSF ... U.S. market”, it has recommended that the drug labels note the varying levels of risks with ...
- Magnevist, Omniscan and OptiMARK Have Highest Risk of NSF, FDA Says 18 Nov 2009 19:56 GMT
... Magnevist, Omniscan and OptiMARK Have Highest Risk of ... U.S. market”, it has recommended that the drug labels note the varying levels of risks with ...
- OptiMARK Gadolinium Contrast Agent Label Changed Over NSF Risk 19 Nov 2009 15:37 GMT
... OptiMARK Gadolinium Contrast Agent Label Changed Over NSF Risk ... U.S. market”, it has recommended that the drug labels note the varying levels of risks with ...
- UPDATE 2-US FDA sees varying risk from MRI agents 17 Nov 2009 23:20 GMT
... * Risk seen highest with GE's Omniscan, Bayer's Magnevist * ... the U.S. market" but recommended that the drug labels note the varying levels of risks with ...
- New source of information can help prescribers and patients in understanding anticipated side effects of treatments 18 Nov 2009 11:51 GMT
... In clinical trials for cancer, it is standard for ... collected in clinical trials and reported in drug labels." ...
- UPDATE 1-US FDA sees varying risk from MRI agents 17 Nov 2009 17:30 GMT
... * Risk seen highest with GE's Omniscan, Bayer's Mangevist * ... the U.S. market" but recommended that the drug labels note the varying levels of risks with ...
- FDA sees varying risk from MRI agents 17 Nov 2009 18:20 GMT
... WASHINGTON (Reuters) - Imaging agents used with MRI ... the U.S. market" but recommended that the drug labels note the varying levels of risks with ...
- Cancer patients and doctors report drug side effects differently 17 Nov 2009 22:39 GMT
... Cancer patients and doctors report drug side effects differently ... collected in clinical trials and reported in drug labels." Funding for this research was provided by ...
- Cancer Patients and Doctors Report Drug Side Effects Differently, but When Combined Improve Reporting of Adverse Events 17 Nov 2009 23:52 GMT
... Cancer Patients and Doctors Report Drug Side Effects Differently, ... collected in clinical trials and reported in drug labels." Funding for this research was provided by ...
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products - new report 20 Nov 2009 11:34 GMT
... Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion ... stance of key stakeholders and implications of off-label drug usage. Understand the role of FDCs in optimizing ...
- Ovarian Cancer Obstacles: Negotiating Financial Barriers to Care 19 Nov 2009 19:13 GMT
... Browse > / Ovarian Cancer Obstacles: Negotiating Financial Barriers to Care ... denial of prescribed chemotherapy treatments due to off-label drug indications, treatments determined by the insurance carrier to ...
- Pharmas Propose Solutions for Web Ad and Social Media Regulations 13 Nov 2009 05:56 GMT
... Pharmas Propose Solutions for Web Ad and Social Media ... drugs. That topic, along with promotion of off-label drug usage in social media, is the intended focus ...
1 - 25 of 28 next >
Powered by 
News by PR Newswire
24-7 pressrelease
Emailwire
|